JP2020532581A5 - - Google Patents

Download PDF

Info

Publication number
JP2020532581A5
JP2020532581A5 JP2020533340A JP2020533340A JP2020532581A5 JP 2020532581 A5 JP2020532581 A5 JP 2020532581A5 JP 2020533340 A JP2020533340 A JP 2020533340A JP 2020533340 A JP2020533340 A JP 2020533340A JP 2020532581 A5 JP2020532581 A5 JP 2020532581A5
Authority
JP
Japan
Prior art keywords
group
independently
alkyl
halogen
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020533340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020532581A (ja
JP7346420B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/104007 external-priority patent/WO2019047826A1/zh
Publication of JP2020532581A publication Critical patent/JP2020532581A/ja
Publication of JP2020532581A5 publication Critical patent/JP2020532581A5/ja
Priority to JP2023144389A priority Critical patent/JP2023158113A/ja
Application granted granted Critical
Publication of JP7346420B2 publication Critical patent/JP7346420B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020533340A 2017-09-05 2018-09-04 芳香族誘導体、その調製方法、およびその医学的適用 Active JP7346420B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023144389A JP2023158113A (ja) 2017-09-05 2023-09-06 芳香族誘導体、その調製方法、およびその医学的適用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710791233 2017-09-05
CN201710791233.1 2017-09-05
PCT/CN2018/104007 WO2019047826A1 (zh) 2017-09-05 2018-09-04 芳香类衍生物、其制备方法及其在医药上的应用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023144389A Division JP2023158113A (ja) 2017-09-05 2023-09-06 芳香族誘導体、その調製方法、およびその医学的適用

Publications (3)

Publication Number Publication Date
JP2020532581A JP2020532581A (ja) 2020-11-12
JP2020532581A5 true JP2020532581A5 (enExample) 2021-10-14
JP7346420B2 JP7346420B2 (ja) 2023-09-19

Family

ID=65634601

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020533340A Active JP7346420B2 (ja) 2017-09-05 2018-09-04 芳香族誘導体、その調製方法、およびその医学的適用
JP2023144389A Pending JP2023158113A (ja) 2017-09-05 2023-09-06 芳香族誘導体、その調製方法、およびその医学的適用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023144389A Pending JP2023158113A (ja) 2017-09-05 2023-09-06 芳香族誘導体、その調製方法、およびその医学的適用

Country Status (10)

Country Link
US (1) US11279697B2 (enExample)
EP (1) EP3680236A4 (enExample)
JP (2) JP7346420B2 (enExample)
KR (1) KR102677016B1 (enExample)
CN (1) CN110997637B (enExample)
CA (1) CA3074885A1 (enExample)
PH (1) PH12020500436A1 (enExample)
SG (1) SG11202001979PA (enExample)
TW (1) TWI817955B (enExample)
WO (1) WO2019047826A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020177067A1 (en) 2019-03-05 2020-09-10 Bioardis Llc Aromatic derivatives, preparation methods, and medical uses thereof
WO2021060307A1 (ja) * 2019-09-25 2021-04-01 富士フイルム株式会社 イミダゾピリジン化合物またはその塩および医薬組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
CA2839437A1 (en) 2011-06-16 2012-12-20 Isis Pharmaceuticals, Inc. Antisense modulation of fibroblast growth factor receptor 4 expression
US8802697B2 (en) 2012-07-11 2014-08-12 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor
US10124003B2 (en) * 2013-07-18 2018-11-13 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for FGFR inhibitor-resistant cancer
CN110354128A (zh) 2013-10-18 2019-10-22 卫材R&D管理有限公司 嘧啶fgfr4抑制剂
AU2014339972B9 (en) 2013-10-25 2019-05-30 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor
MX367723B (es) 2013-10-25 2019-09-03 Novartis Ag Compuestos de anillos fusionados bicíclicos derivados de piridilo como inhibidores de fgfr4.
JP6655559B2 (ja) 2014-06-24 2020-02-26 コベストロ、ドイチュラント、アクチエンゲゼルシャフトCovestro Deutschland Ag ジフェニルメタン系ジアミンおよびポリアミンの製造方法
WO2016064960A1 (en) * 2014-10-22 2016-04-28 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
EP3029864B1 (en) 2014-12-01 2020-11-18 Harman Becker Automotive Systems GmbH Fast representation of station information in a fm receiver using a single tuner
ES2895769T3 (es) 2015-02-20 2022-02-22 Incyte Corp Heterociclos bicíclicos como inhibidores de FGFR
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en) * 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
CN105906630B (zh) * 2015-04-06 2018-10-23 四川百利药业有限责任公司 用作fgfr抑制剂的n-(1h-吡唑-5-基)嘧啶并吡唑-4,6-二取代胺类化合物
WO2016164703A1 (en) * 2015-04-09 2016-10-13 Eisai R & D Management Co., Ltd. Fgfr4 inhibitors
CN109224235B (zh) 2018-10-23 2020-05-19 孙喜家 一种双腔管
CN109331654A (zh) 2018-10-26 2019-02-15 高邮高和光电器材有限公司 一种有机废气光催化氧化装置

Similar Documents

Publication Publication Date Title
JP2014193925A5 (enExample)
JP2020517616A5 (enExample)
JP2018520195A5 (enExample)
JP2019524883A5 (enExample)
JP2009525353A5 (enExample)
JP2017538677A5 (enExample)
JP2020007311A5 (enExample)
RU2016118753A (ru) Производные пиридилкетона, способ их получения и их фармацевтическое применение
CA2519898A1 (en) Oral administration of cyclic protein tyrosine kinase inhibitors
JP2015518899A5 (enExample)
RU2011107278A (ru) Пиримидиновые соединения, композиции и способы применения
JP2011511095A5 (enExample)
JP2011515397A5 (enExample)
JP2012505916A5 (enExample)
JP2019535746A5 (enExample)
JP2011522889A5 (enExample)
JP2014521653A5 (enExample)
CN107548391A (zh) 嘧啶或吡啶类化合物、其制备方法和医药用途
JP2012505235A5 (enExample)
RU2005122901A (ru) Производные пиридино [2,3-] пиримидина в качестве селективных ингибиторов kdr и fgfr
ME02630B (me) Makrociklički derivati, namijenjeni liječenju proliferativnih bolesti
JP2011529920A5 (enExample)
JP2019500315A5 (enExample)
RU2017136715A (ru) Производное имидазоизоиндола, способ его получения и медицинское применение
JP2019522055A5 (enExample)